A previous report [70] identified CD44 as the sole marker analyzed that exhibited a positive correlation with GBM cell radioresistance, and found a negative correlation between radioresistance and the expression of SLGC-associated factors, such as Nestin, Sox2, CD133, and Musashi. The gene discussed is CD44; the disease is glioblastoma.